Priority Review decision is based on phase III MAJESTY results, where Gazyva/Gazyvaro achieved significantly higher complete remission rates at two years compared to tacrolimus1 If approved, Gazyva/Ga ...

A new medical rulebook just took effect — and your next checkup could land a disease label on your chart.

Black kidney donors with the high-risk APOL1 genotype are about twice as likely to develop reduced kidney function as those without it. Medical algorithms consider all Black kidney donor candidates as ...

Up to 93% of kidney cancers can be cured if they are found early. But once cancer spreads outside the kidney, it is much harder to treat. That’s why it’s important to bring up any concerning symptoms ...

The drug finerenone significantly slows the decline in kidney function in patients with chronic kidney disease (CKD) who do not have diabetes. This is shown by an international study led by clinical ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to buy right now. On May 19, IDEXX Laboratories, Inc. (NASDAQ:IDXX) announced that its SDMA kidney biomarker will be ...

Philadelphia — University of Pennsylvania researchers are developing a blood test to better predict the risk of kidney disease in Black Americans, a group that is disproportionately affected in part ...

Value‑based care has long promised better outcomes at lower cost. The real question was whether that promise could hold in the most complex, high‑need corners of healthcare. Kidney care provides the ...

Earnings call Vivoryon Therapeutics reported a significantly narrowed net loss of EUR 8.9M for 2025 (vs EUR 20.6M in 2024), driven by sharply reduced R&D and G&A expenses. The company extended its ...

A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.

PHILADELPHIA— A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease ...

This article is part of “Innovations In: Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. Dennis Moledina encountered a common problem ...